Thomas A. Boyd
Nessuna posizione attualmente
Profilo
Thomas A.
Boyd worked as Senior Vice President-Product Development at Progenics Pharmaceuticals, Inc. from 2000 to 2010 and as Associate Director-Research & Development at Boehringer Ingelheim Pharmaceuticals, Inc. from 1996 to 2000.
He holds a doctorate degree from Brown University and an undergraduate degree from Cornell University.
Precedenti posizioni note di Thomas A. Boyd
Società | Posizione | Fine |
---|---|---|
PROGENICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 13/08/2010 |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Direttore Tecnico/Scientifico/R&S | 02/01/2000 |
Formazione di Thomas A. Boyd
Cornell University | Undergraduate Degree |
Brown University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
- Borsa valori
- Insiders
- Thomas A. Boyd